Clinical Trial Update: A Study of the Effect of Lenalidamide on Complex Regional Pain Syndrome Type 1 [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating lenalidamide for Complex Regional Pain Syndrome Type 1 has completed. The study was sponsored by Mayo Clinic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complex Regional Pain Syndrome Type 1

Drugs mentioned

• Lenalidamide (lenalidomide)

Snippet

Sponsor: Mayo Clinic | Conditions: Complex Regional Pain Syndrome, Type 1 | Phase 3 | Status: COMPLETED